NPI registry status
Active
2026 NPPES data Allergy Physician NPI 1306808928 MD
Verify on CMS → Martha Tarpay, MD
Allergy Physician in Oklahoma City, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,015 in Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
728
Medicare Part D claims · 122 beneficiaries · Allergy Physician avg: 805
Generic prescribing
0%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.6K
48 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Martha Tarpay, MD filed 728 Medicare Part D claims in 2024 as an Allergy Physician in Oklahoma City, Oklahoma, prescribing 0% generic.
- 728
- Part D claims, 2024
- 0%
- generic prescribing
- $1.6K
- industry payments (Sunshine Act)
- ≥70th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Martha Tarpay, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1306808928), first enumerated 04/06/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 728 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$1.6K in reported industry payments (48 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1306808928 · Allergy Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1306808928
- ENUM-LEGACY 2006
- TAX-NARROW 1,015
- RX-LIGHT 728
- BOOK-THIN 8 in Oklahoma
- PHOTO-ENUM Tommy Sim, M.D. · 2006
Martha Tarpay, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
728 ≥ 70th percentile 70% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Martha Tarpay, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Martha Tarpay, MD?
Quality data not reportedPrimary specialty
Allergy Physician
Medicare Part D claims
728 10% vs specialty avg
Specialty distribution in Oklahoma
How Allergy Physician compares to other specialties among Oklahoma providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Allergy Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1306808928 |
|---|---|
| Specialty | Allergy Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/06/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Martha Tarpay, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.6K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Martha Tarpay, MD - brand share 51.0%
Allergy Physician average
51% brand-name claims vs 0% generic, on 728 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
728
Total Claims
$787K
Total Drug Cost
122
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,068.7
- Total Day Supply
- 30,577
- Brand vs Generic
- 51% brand / 0% generic
- Brand Drug Cost
- $773K
- Antibiotic Claims
- 28
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 1.25
- Gender Split
- 77% female / 23% male
- Age Distribution
- <65: 15, 65-74: 72, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Martha Tarpay, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Montelukast Sodium
Montelukast Sodium
144 claims
- Breztri Aerosphere
Breztri Aerosphere
73 claims
- Symbicort
Symbicort
58 claims
- Azelastine Hcl 47
Azelastine Hcl
47 claims
- Albuterol Sulfate … 45
Albuterol Sulfate Hfa
45 claims
- Advair Hfa 42
Advair Hfa
42 claims
- Qvar Redihaler 39
Qvar Redihaler
39 claims
- Trelegy Ellipta 26
Trelegy Ellipta
26 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 144 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 73 |
| Symbicort Budesonide/Formoterol Fumarate | 58 |
| Azelastine Hcl | 47 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 45 |
| Advair Hfa Fluticasone Propion/Salmeterol | 42 |
| Qvar Redihaler Beclomethasone Dipropionate | 39 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 26 |
| Doxycycline Hyclate | 24 |
| Fluticasone Propionate | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy Physician Overview
How Martha Tarpay, MD fits within the Allergy Physician landscape nationally.
1,015
Allergy Physician Providers in US
50
States with Allergy Physician
805
Avg Claims per Provider
Martha Tarpay, MD's 728 claims are below the specialty average of 805.
Nationwide Allergy Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Tarpay, both outside Oklahoma so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Allergy Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Tarpay.
One of 8 Allergy Physician providers enrolled in Oklahoma, 5 are shown here.
Dr. David Hurewitz
MD
Tulsa, OK
Dr. James Love
MD
Tulsa, OK
Dr. Lodie Naimeh
MD
Tulsa, OK
Dr. Timothy Nickel
MD
Tulsa, OK
Dr. Suzanne Olive
MD
Tulsa, OK
Compare Allergy Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Martha Tarpay, MD's specialty? ▼
Martha Tarpay, MD specializes in Allergy Physician and practices in Oklahoma City, Oklahoma. Credentials: MD.
How much does Martha Tarpay, MD prescribe under Medicare Part D? ▼
In 2024, Martha Tarpay, MD wrote 728 Medicare Part D claims totaling $787K in drug costs for 122 beneficiaries.
Where is Martha Tarpay, MD located? ▼
Martha Tarpay, MD is located at 4200 W MEMORIAL RD, Oklahoma City, OK, 73120. Phone: (405) 752-0393.
What is Martha Tarpay, MD's NPI number? ▼
Martha Tarpay, MD's National Provider Identifier (NPI) is 1306808928, issued on 04/06/2006.
Does Martha Tarpay, MD prescribe more brand-name or generic drugs? ▼
Martha Tarpay, MD's prescribing is 51% brand-name and 0% generic drugs by claim count, with $773K in brand drug costs.
How many Allergy Physician providers are there in the US? ▼
There are 1,015 Allergy Physician providers across 50 states in the US. The average Allergy Physician provider writes 805 Medicare Part D claims per year.
What drugs does Martha Tarpay, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Martha Tarpay, MD's most frequently prescribed drugs include Montelukast Sodium, Breztri Aerosphere, Symbicort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Martha Tarpay, MD accept Medicare? ▼
Martha Tarpay, MD appears in CMS Medicare data with 728 Part D claims and 122 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Martha Tarpay, MD's credentials? ▼
Martha Tarpay, MD's NPI is 1306808928 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.